Sanofi to Join Alzheimer's Space With Vigil Neuroscience Buyout

• click to rate

  Posted by Two Blokes May 22 - Filed in Stock - 2 views
  
  SNY inks an agreement to acquire VIGL and its pipeline candidate VG-3927, which is being developed to treat Alzheimer's disease.